New report reveals the latest drug trends in Europe
by Brian Galvin
In June 2015 the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) published the European drug report 2015: trends and developments, summarising the latest trends across the 28 EU member states, and Norway and Turkey.1 The European drug report highlights changing dynamics in the heroin market, with an overall stagnation in the demand for heroin in Europe. The report warns, however, that an increase in production in most of the countries supplying Europe with heroin could result in more of the drug becoming available in European drug markets. Other changes in market dynamics, including processing of heroin inside Europe, the emergence of alternative trafficking routes and diversification of products from opioid-producing countries in Asia, need to be monitored carefully. As the age profile of heroin users increases, providing appropriate treatment and care to long-term users is a growing challenge for drug treatment and social services.
Full story »
EMCDDA select new director
by Brian Galvin
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has selected Alexis Goosdeel (Belgium) as the agency's new Director, starting on 1 January 2016. Mr Goosdeel, a psychologist with a background in public health, has been head of the EMCDDA's Reitox and international relations unit since 2005. This work involves coordinating a network of 30 national drug monitoring centres and preparing EU candidate and potential candidate countries for membership of the EMCDDA.
Full story »
Ireland's national suicide strategy 2015-2010, and the evidence base
by Jean Long
On 18 June 2015 the Taoiseach, Enda Kenny TD, launched Ireland’s national suicide strategy Connecting for life.1 The strategy envisions an Ireland where fewer lives are lost through suicide, and where communities and individuals are empowered to improve their mental health and wellbeing. This vision will be achieved through seven goals:
Full story »
|
|
